Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy
Miyamura, Koichi, MD, Miyamoto, Toshihiro, MD, Tanimoto, Mitsune, MD, Yamamoto, Kazuhito, MD, Kimura, Shinya, MD, Kawaguchi, Tatsuya, MD, Matsumura, Itaru, MD, Hata, Tomoko, MD, Tsurumi, Hisashi, MD, Saito, Shigeki, MD, Hino, Masayuki, MD, Tadokoro, Seiji, MD, Meguro, Kuniaki, MD, Hyodo, Hideo, MD, Yamamoto, Masahide, MD, Kubo, Kohmei, MD, Tsukada, Junichi, MD, Kondo, Midori, Aoki, Makoto, Okada, Hikaru, MD, Yanada, Masamitsu, MD, Ohyashiki, Kazuma, MD, Taniwaki, Masafumi, MD
Published in Leukemia research (01.12.2016)
Published in Leukemia research (01.12.2016)
Get full text
Journal Article